Alpha 2.0
Login Register
» Authors » Riwanti Estiasari

Riwanti Estiasari

Explore the profile of Riwanti Estiasari including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 48
Citations 154
Followers 0
Related Specialties
Neurology
Infectious Diseases
Allergy & Immunology
Top 10 Co-Authors
Darma Imran
Kartika Maharani
Patricia Price
Silvia Lee
David Pangeran
Reinout van Crevel
Raph L Hamers
Sofiati Dian
Ibnu A Ariyanto
Ahmad Rizal Ganiem
Published In
J Clin Apher
Neurol Res Int
Clin Immunol
J Acquir Immune Defic Syndr
J Cent Nerv Syst Dis
Affiliations
Soon will be listed here.
Recent Articles
1.
Tuberculous meningitis patient pathways and delays to diagnosis in Indonesia: a retrospective cohort study
Nijman G, Imran D, Dian S, Ganiem A, Estiasari R, Maharani K, et al.
BMJ Public Health . 2025 Feb; 1(1):e000052. PMID: 40017887
Introduction: Delays in diagnosis and treatment contribute to high mortality of tuberculous meningitis (TBM). We studied TBM patient pathways including delays to diagnosis, and their alignment with available diagnostic services...
2.
The association between abcb1 gene polymorphism and clopidogrel response variability in stroke ischemic: a cross sectional study
Hidayat R, Nabilah R, Fisher M, Aninditha T, Kurniawan M, Estiasari R, et al.
BMC Neurol . 2024 Jun; 24(1):216. PMID: 38914966
Background: Clopidogrel has been the primary choice of antiplatelet in ischemic stroke that inhibits adenosine diphosphate (ADP)-induced platelet aggregation. P-glycoprotein (P-gp) multidrug resistance-1 (MDR1) is a transmembrane efflux transporter in...
3.
Multidisciplinary re-evaluation of neuropsychiatric events to confirm the neuropsychiatric lupus diagnosis at an Indonesian tertiary hospital
Estiasari R, Banu S, Widhani A, Octaviana F, Maharani K, Aninditha T, et al.
Lupus Sci Med . 2024 Jun; 11(1). PMID: 38851218
Objective: Neuropsychiatric SLE (NPSLE) has a broad spectrum and to date, there is no gold-standard biomarker. The diagnosis relies on clinical assessment, supporting examinations and exclusion of other possible aetiologies....
4.
Multi-actor system dynamics in access to disease-modifying treatments for multiple sclerosis in Southeast Asia: A regional survey and suggestions for improvement
Viswanathan S, Vijayasingham L, Laurson-Doube J, Quek A, Tan K, Yeo T, et al.
Mult Scler Relat Disord . 2024 Mar; 85:105555. PMID: 38547547
Background: Despite the global availability of multiple sclerosis (MS) treatments, accessing and financing them in Southeast Asia (SEA) remains a challenge. This descriptive survey-based study aimed to describe the current...
5.
Clinical presentation, management, and outcome of suspected central nervous system infections in Indonesia: a prospective cohort study
Maharani K, Dian S, Ganiem A, Imran D, Estiasari R, Ardiansyah E, et al.
Infection . 2024 Feb; 52(2):583-595. PMID: 38315377
Background: Little is known about the etiology, clinical presentation, management, and outcome of central nervous system (CNS) infections in Indonesia, a country with a high burden of infectious diseases and...
6.
Effectiveness of transcranial direct current stimulation (tDCS) as adjunctive treatment for chronic headache in adults with clinically stable systemic lupus erythematosus (SHADE): a randomised double-blind multiarm sham controlled clinical trial
Estiasari R, Tiksnadi A, Tunjungsari D, Maharani K, Aninditha T, Sofyan H, et al.
BMJ Open . 2023 Dec; 13(12):e076713. PMID: 38101851
Background: Chronic headache is a 'silent' neuropsychiatric systemic lupus erythematosus symptom with heterogeneous prevalence, potentially reaching 54.4%. It may reduce quality of life by increasing the likelihood of depression and...
7.
Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults
Donovan J, Bang N, Imran D, Nghia H, Burhan E, Huong D, et al.
N Engl J Med . 2023 Oct; 389(15):1357-1367. PMID: 37819954
Background: Adjunctive glucocorticoids are widely used to treat human immunodeficiency virus (HIV)-associated tuberculous meningitis despite limited data supporting their safety and efficacy. Methods: We conducted a double-blind, randomized, placebo-controlled trial...
8.
Effect of atorvastatin on subclinical atherosclerosis in virally-suppressed HIV-infected patients with CMV seropositivity: a randomized double-blind placebo-controlled trial
Yunihastuti E, Rusdi L, Azizi M, Estiasari R, Jasirwan C, Wulandari E, et al.
F1000Res . 2023 Sep; 10:151. PMID: 37772075
Persistent immune activation and inflammation in HIV-infection are linked to excess cardiovascular risk and other non-communicable diseases. Periodic asymptomatic CMV-reactivity in HIV infected patients over a lifetime may contribute to...
9.
Prognostic identifier of cerebrovascular complications in tuberculous meningitis: Meta-analysis
Tomidy J, Satriadinatha G, Liwang F, Maharani K, Imran D, Estiasari R
J Stroke Cerebrovasc Dis . 2023 Sep; 32(11):107371. PMID: 37738916
Introduction: Cerebrovascular complications could occur in 15-57 % of patients with tuberculous meningitis (TBM). It is crucial to rapidly identify TBM patients who are at risk for stroke. This study...
10.
Tryptophan metabolism determines outcome in tuberculous meningitis: a targeted metabolomic analysis
Ardiansyah E, Avila-Pacheco J, Nhat L, Dian S, Vinh D, Hai H, et al.
Elife . 2023 May; 12. PMID: 37158692
Background: Cellular metabolism is critical for the host immune function against pathogens, and metabolomic analysis may help understand the characteristic immunopathology of tuberculosis. We performed targeted metabolomic analyses in a...